ArticleCancer reports (Hoboken, N.J.)2025

Assessing the Comparative Efficacy and Safety of Warfarin and Rivaroxaban for Cancer Associated Thrombosis: Experience From a Resource Limited Setting.

Abel Tenaw Tasamma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.